Hookipa Pharma Inc. News Releases https://ir.hookipapharma.com/ Hookipa Pharma Inc. News Releases en HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-pharma-reports-first-quarter-2019-financial-results-and NEW YORK and VIENNA, Austria, May 20, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform, today reported recent business highlights and financial Mon, 20 May 2019 16:00:52 -0400 Hookipa Pharma Inc. News Releases 6691 HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-achieves-research-milestone-hbv-collaboration-and NEW YORK and VIENNA, Austria, May 08, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that it has achieved a further research Wed, 08 May 2019 03:47:46 -0400 Hookipa Pharma Inc. News Releases 6651 HOOKIPA Appoints David R. Kaufman to its Board of Directors https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-appoints-david-r-kaufman-its-board-directors NEW YORK and VIENNA, Austria, April 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the appointment of David R. Thu, 25 Apr 2019 08:30:20 -0400 Hookipa Pharma Inc. News Releases 6611 HOOKIPA Pharma Announces Pricing of Initial Public Offering https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-pharma-announces-pricing-initial-public-offering Wed, 17 Apr 2019 08:00:00 -0400 Hookipa Pharma Inc. News Releases 6496 HOOKIPA Pharma Raises $37.4 million (€33.2 million) in Series D Financing https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-pharma-raises-374-million-eu332-million-series-d Tue, 26 Feb 2019 08:00:00 -0500 Hookipa Pharma Inc. News Releases 6286 HOOKIPA Appoints Michael A. Kelly as Independent Director https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-appoints-michael-kelly-independent-director Fri, 15 Feb 2019 08:00:00 -0500 Hookipa Pharma Inc. News Releases 6291 HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-achieves-first-research-milestone-hiv-collaboration-and Wed, 02 Jan 2019 08:00:00 -0500 Hookipa Pharma Inc. News Releases 6281 HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-doses-first-patient-phase-2-clinical-trial-prophylactic Mon, 17 Dec 2018 08:00:00 -0500 Hookipa Pharma Inc. News Releases 6276 Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement https://ir.hookipapharma.com/news-releases/news-release-details/valneva-and-hookipa-sign-collaboration-and-manufacturing Thu, 06 Dec 2018 00:00:00 -0500 Hookipa Pharma Inc. News Releases 6616 HOOKIPA and DarwinHealth Enter into a Research Collaboration and License Agreement to Discover and Prioritize Novel Immunogenic, Tumor-Specific Cryptic Antigens https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-and-darwinhealth-enter-research-collaboration-and Wed, 28 Nov 2018 08:00:00 -0500 Hookipa Pharma Inc. News Releases 6271